Jesse Gelsinger's is a cautionary tale in gene therapy research, again in the spotlight due to COVID-19.
from USATODAY - News Top Stories https://ift.tt/wxUd9r1
via
-->
Jesse Gelsinger's is a cautionary tale in gene therapy research, again in the spotlight due to COVID-19.